Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 3.5B | 4.1B | 3.8B | 3.7B |
Cost of revenue | 2.0B | 2.5B | 2.2B | 2.1B |
Gross profit | 1.4B | 1.6B | 1.6B | 1.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 260M | 259M | 355M | 293M |
Non operating interest income | ||||
Income | 26M | 32M | 29M | 27M |
Expense | 23M | 19M | 23M | 24M |
Other income expense | — | — | — | — |
Pretax income | 263M | 272M | 361M | 296M |
Tax provision | 70M | 66M | 87M | 90M |
Net income | 193M | 206M | 274M | 206M |
Basic EPS | 0.5 | 0.6 | 0.7 | 0.6 |
Diluted EPS | 0.5 | 0.5 | 0.7 | 0.5 |
Basic average shares | 375M | 377M | 377M | 376M |
Diluted average shares | 382M | 384M | 383M | 383M |
EBITDA | 407M | 420M | 508M | 443M |
Net income from continuing op. | 193M | 206M | 274M | 206M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |